← Back to Search

Virtual Reality (VR) Meditation for Healthy Aging

N/A
Waitlist Available
Led By Bassam Khoury, PhD
Research Sponsored by McGill University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline (week 1), mid-point (week 3), post-intervention (week 5) and follow-up (week 9)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a VR program called 'Toujours Dimanche' designed to improve mental health in older adults. Participants use VR headsets to experience nature and guided meditation sessions regularly. The goal is to see if this immersive experience can reduce stress and improve well-being.

Eligible Conditions
  • Healthy Aging
  • Mental Health Wellness

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline (week 1), mid-point (week 3), post-intervention (week 5) and follow-up (week 9)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline (week 1), mid-point (week 3), post-intervention (week 5) and follow-up (week 9) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change from Baseline in Scores on the Flourishing Scale (FS)
Change from Baseline in Scores on the General Self-Efficacy Scale (GSE)
Change from Baseline in Scores on the Perceived Stress Scale (PSS)
+1 more
Secondary study objectives
Change from Baseline in Scores on the Connectedness to Nature Scale (CNS)
Change from Baseline in Scores on the Embodied Mindfulness Questionnaire (EMQ)
Change from Baseline in Scores on the Five Facet Mindfulness Questionnaire-Short Form (FFMQ-24)
+1 more
Other study objectives
Change from Time 1 in Scores on the Simulator Sickness Questionnaire (SSQ)
Researcher Developed Virtual Reality Program Satisfaction Questionnaire

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Virtual Reality (VR) MeditationExperimental Treatment1 Intervention
The VR Meditation intervention will be administered in Arm 1.
Group II: Psychoeducational PamphletsActive Control1 Intervention
The Psychoeducation Pamphlet intervention will be administered in Arm 2.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality (VR) Meditation
2022
N/A
~30

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor
410 Previous Clinical Trials
1,018,448 Total Patients Enrolled
1 Trials studying Healthy Aging
93 Patients Enrolled for Healthy Aging
Super Sublime | Super SplendideUNKNOWN
Résidences EnharmonieUNKNOWN

Media Library

Virtual Reality (VR) Meditation Clinical Trial Eligibility Overview. Trial Name: NCT05531513 — N/A
Healthy Aging Research Study Groups: Virtual Reality (VR) Meditation, Psychoeducational Pamphlets
Healthy Aging Clinical Trial 2023: Virtual Reality (VR) Meditation Highlights & Side Effects. Trial Name: NCT05531513 — N/A
Virtual Reality (VR) Meditation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05531513 — N/A
~7 spots leftby Nov 2025